Literature DB >> 3699306

Progression of subclinical polyneuropathy in young patients with type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications).

R J Young, C C Macintyre, C N Martyn, R J Prescott, D J Ewing, A F Smith, G Viberti, B F Clarke.   

Abstract

The progression of subclinical polyneuropathy over 2.5 years has been studied in a representative group of 75 young patients with Type 1 (insulin-dependent) diabetes (initial age 16-19 years). The relationships between changes in nerve function, glycaemic control and concurrently developing microvascular complications (retinopathy, microproteinuria) were investigated. Deterioration of motor, sensory and autonomic nerve function, retinopathy and microproteinuria was related to poor glycaemic control. In addition, there was an association between developing neural and microvascular complications which was not diminished when their common relationship to hyperglycaemia was taken into account. These findings suggest that, although poor glycaemic control is an essential permissive factor in the early development of diabetic polyneuropathy, other influences, shared with microvascular complications, must also be important.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699306     DOI: 10.1007/bf02427086

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Improvement in nerve conduction following treatment in newly diagnosed diabetics.

Authors:  J D Ward; C G Barnes; D J Fisher; J D Jessop; R W Baker
Journal:  Lancet       Date:  1971-02-27       Impact factor: 79.321

2.  Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study.

Authors:  R R Holman; T L Dornan; V Mayon-White; J Howard-Williams; C Orde-Peckar; L Jenkins; J Steemson; R Rolfe; B Smith; D Barbour; K McPherson; P Poon; C Rizza; J I Mann; A H Knight; A J Bron; R C Turner
Journal:  Lancet       Date:  1983-01-29       Impact factor: 79.321

3.  Alcohol: another risk factor for diabetic retinopathy?

Authors:  R J Young; D K McCulloch; R J Prescott; B F Clarke
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

Review 4.  Diabetic neuropathy.

Authors:  M J Brown; A K Asbury
Journal:  Ann Neurol       Date:  1984-01       Impact factor: 10.422

5.  Clinical implications of labile HbA1 as assayed by the electrophoretic method.

Authors:  L Tibi; R J Young; A F Smith
Journal:  Clin Chim Acta       Date:  1982-12-23       Impact factor: 3.786

6.  Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy.

Authors:  A J Boulton; J Drury; B Clarke; J D Ward
Journal:  Diabetes Care       Date:  1982 Jul-Aug       Impact factor: 19.112

Review 7.  Diabetic autonomic neuropathy.

Authors:  B F Clarke; D J Ewing; I W Campbell
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

8.  A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy.

Authors:  R J Young; D J Ewing; B F Clarke
Journal:  Diabetes       Date:  1983-10       Impact factor: 9.461

9.  Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.

Authors:  R J Graf; J B Halter; M A Pfeifer; E Halar; F Brozovich; D Porte
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

Review 10.  Diagnostic, pathogenetic, and therapeutic aspects of diabetic neuropathy.

Authors:  R S Clements; D S Bell
Journal:  Spec Top Endocrinol Metab       Date:  1982
View more
  18 in total

1.  Comparison of electrophysiologic and autonomic tests in sensory diabetic neuropathy.

Authors:  M Kihara; M Mitsui; S Nishikawa; K Nishimoto; M Takahashi
Journal:  Clin Auton Res       Date:  1998-08       Impact factor: 4.435

2.  Impact of glycemic control on heart rate variability in youth with type 1 diabetes: the SEARCH CVD study.

Authors:  Mamta Jaiswal; Tasha E Fingerlin; Elaine M Urbina; R Paul Wadwa; Jennifer W Talton; Ralph B D'Agostino; Richard F Hamman; Stephen R Daniels; Santica M Marcovina; Larry M Dolan; Dana Dabelea
Journal:  Diabetes Technol Ther       Date:  2013-09-06       Impact factor: 6.118

3.  Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.

Authors:  D Ziegler; K Wiefels; K Dannehl; F A Gries
Journal:  Klin Wochenschr       Date:  1988-05-02

4.  The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes.

Authors:  D Ziegler; I Cicmir; P Mayer; K Wiefels; F A Gries
Journal:  Klin Wochenschr       Date:  1988-11-01

5.  Can prepregnancy care of diabetic women reduce the risk of abnormal babies?

Authors:  J M Steel; F D Johnstone; D A Hepburn; A F Smith
Journal:  BMJ       Date:  1990-11-10

6.  C-peptide improves autonomic nerve function in IDDM patients.

Authors:  B L Johansson; K Borg; E Fernqvist-Forbes; T Odergren; S Remahl; J Wahren
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

7.  Medial arterial calcification and its association with mortality and complications of diabetes.

Authors:  J E Everhart; D J Pettitt; W C Knowler; F A Rose; P H Bennett
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

8.  Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy.

Authors:  S R Crosby; C Tsigos; C D Anderton; C Gordon; R J Young; A White
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

9.  The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus.

Authors:  D Ziegler; P Mayer; H Mühlen; F A Gries
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

10.  Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects--a 5-year follow-up.

Authors:  J M Lehtinen; L Niskanen; K Hyvönen; O Siitonen; M Uusitupa
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.